- Home
- WNW vs CYTO Comparison
WNW vs CYTO Comparison
Compare WNW & CYTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- CYTO
- Stock Information
- Founded
- WNW 2015
- CYTO 2003
- Country
- WNW China
- CYTO Bermuda
- Employees
- WNW N/A
- CYTO N/A
- Industry
- WNW Catalog/Specialty Distribution
- CYTO Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- CYTO Health Care
- Exchange
- WNW Nasdaq
- CYTO Nasdaq
- Market Cap
- WNW 2.5M
- CYTO 2.2M
- IPO Year
- WNW 2020
- CYTO N/A
- Fundamental
- Price
- WNW $0.85
- CYTO $0.46
- Analyst Decision
- WNW
- CYTO
- Analyst Count
- WNW 0
- CYTO 0
- Target Price
- WNW N/A
- CYTO N/A
- AVG Volume (30 Days)
- WNW 54.4K
- CYTO 106.0K
- Earning Date
- WNW 11-26-2024
- CYTO 09-24-2024
- Dividend Yield
- WNW N/A
- CYTO N/A
- EPS Growth
- WNW N/A
- CYTO N/A
- EPS
- WNW N/A
- CYTO N/A
- Revenue
- WNW $380,345.00
- CYTO N/A
- Revenue This Year
- WNW N/A
- CYTO N/A
- Revenue Next Year
- WNW N/A
- CYTO N/A
- P/E Ratio
- WNW N/A
- CYTO N/A
- Revenue Growth
- WNW N/A
- CYTO N/A
- 52 Week Low
- WNW $0.71
- CYTO $0.40
- 52 Week High
- WNW $11.11
- CYTO $17.20
- Technical
- Relative Strength Index (RSI)
- WNW 62.13
- CYTO 35.16
- Support Level
- WNW $0.76
- CYTO $0.40
- Resistance Level
- WNW $0.83
- CYTO $0.62
- Average True Range (ATR)
- WNW 0.04
- CYTO 0.06
- MACD
- WNW 0.01
- CYTO 0.00
- Stochastic Oscillator
- WNW 75.76
- CYTO 25.18
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform, which generates nearly all of its revenue; Restaurant; and Others.
About CYTO Altamira Therapeutics Ltd.
Altamira Therapeutics Ltd is dedicated to developing therapeutics that address unmet medical needs. It is active in RNA therapeutics, allergy and viral infections, and inner ear disorders. Its product Bentrio is a drug-free nasal spray for personal protection against airborne viruses and allergens. The company's OligoPhore / SemaPhore platform is a versatile system that allows the complexation of therapeutic RNAs with a proprietary peptide to form a nanoparticle formulation. This formulation allows to deliver of therapeutic RNA by systemic administration to tissues affected by leaky vasculature, a hallmark of solid tumors and certain inflammatory conditions.